MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GANX has $22,818,975 in assets. $4,254,227 in debts. $20,837,628 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
663.32%
Quick Ratio
663.32%
Cash Ratio
621.57%
Debt to Asset Ratio
18.64%
Unit: Dollar
Assets Breakdown
    • Operating lease right-of-use ass...
    • Tax credits
    • Restricted cash
    • Long-term deposits and other non...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Loss of the period
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
20,837,628
Tax credits
179,701
Prepaid expenses and other current assets
1,219,809
Total current assets
22,237,138
Property and equipment, net
74,916
Internal-use software, net
102,837
Operating lease right-of-use assets
334,090
Restricted cash
36,296
Long-term deposits and other noncurrent assets
33,698
Total noncurrent assets
581,837
Total assets
22,818,975
Accounts payable
825,027
Operating lease liabilities - current
119,876
Other current liabilities
2,306,624
Loans - current
100,869
Total current liabilities
3,352,396
Defined benefit pension plan
390,509
Operating lease liabilities - noncurrent
211,238
Loans - noncurrent
300,084
Total noncurrent liabilities
901,831
Total liabilities
4,254,227
Common stock, 0.0001 par value 100,000,000 shares authorized 42,073,807 and 27,132,588 shares issued and outstanding as of december 31, 2025 and 2024, respectively
4,209
Additional paid-in capital
119,139,677
Accumulated other comprehensive income (loss)
776,869
Accumulated deficit
-81,194,908
Loss of the period
-20,161,099
Total stockholders' equity
18,564,748
Total liabilities and stockholders' equity
22,818,975
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$20,837,628 Prepaid expenses andother current assets$1,219,809 Tax credits$179,701 Operating leaseright-of-use assets$334,090 Internal-use software, net$102,837 Property and equipment,net$74,916 Restricted cash$36,296 Long-term deposits andother noncurrent...$33,698 Total current assets$22,237,138 Total noncurrentassets$581,837 Total assets$22,818,975 Total liabilities andstockholders' equity$22,818,975 Total stockholders'equity$18,564,748 Total liabilities$4,254,227 Accumulated deficit-$81,194,908 Loss of the period-$20,161,099 Additional paid-in capital$119,139,677 Total currentliabilities$3,352,396 Total noncurrentliabilities$901,831 Accumulated othercomprehensive income (loss)$776,869 Common stock, 0.0001par value...$4,209 Other currentliabilities$2,306,624 Accounts payable$825,027 Operating leaseliabilities - current$119,876 Loans - current$100,869 Defined benefit pensionplan$390,509 Loans - noncurrent$300,084 Operating leaseliabilities - noncurrent$211,238

Gain Therapeutics, Inc. (GANX)

Gain Therapeutics, Inc. (GANX)